Three ALL cells, namely BALL-1 (CD19+CD20+), REH (CD19+CD20−), and Jurkat (CD19−CD20−), were selected for further experimentation based on their expression levels. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.